Sunday , September 29 2024
Home / Mike Norman Economics / GSK to collaborate with Chinese biotech on COVID-19 vaccine

GSK to collaborate with Chinese biotech on COVID-19 vaccine

Summary:
GlaxoSmithKline has announced plans to collaborate with China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 coronavirus.GSK to collaborate with Chinese biotech on COVID-19 vaccine

Topics:
Mike Norman considers the following as important:

This could be interesting, too:

Bill Haskell writes Cage Wrestling Returns on October 1 Vance v Walz

Joel Eissenberg writes The key to longevity

Bill Haskell writes the “Alabamization of America”

Bill Haskell writes Comet in the sky in the early morning in AZ

GlaxoSmithKline has announced plans to collaborate with China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 coronavirus.

GSK to collaborate with Chinese biotech on COVID-19 vaccine

Mike Norman
Mike Norman is an economist and veteran trader whose career has spanned over 30 years on Wall Street. He is a former member and trader on the CME, NYMEX, COMEX and NYFE and he managed money for one of the largest hedge funds and ran a prop trading desk for Credit Suisse.

Leave a Reply

Your email address will not be published. Required fields are marked *